Promethium Advisors’s Eli Lilly LLY Stock Holding History

Promethium Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.21M	Buy	1,042 +42	+4%	+$49.6K	0.59%	47
2026 Q2	$1.2M	Hold	1,000	–	–	0.58%	49
2026 Q1	$920K	Hold	1,000	–	–	0.48%	59
2025 Q4	$1.07M	Hold	1,000	–	–	0.58%	53
2025 Q3	$763K	Hold	1,000	–	–	0.44%	60
2025 Q2	$780K	Hold	1,000	–	–	0.47%	59
2025 Q1	$826K	Hold	1,000	–	–	0.53%	51
2024 Q4	$772K	Hold	1,000	–	–	0.53%	55
2024 Q3	$886K	Buy	+1,000	New	+$899K	0.63%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Promethium Advisors's LLY Position: Q3 2026 in Review

Promethium Advisors increased its Eli Lilly (LLY) stake by 4.2% in Q3 2026, buying an estimated $49.6K and bringing the position to 1,042 shares worth $1.21M. The position accounts for 0.59% of the portfolio, ranked #47.

Promethium Advisors first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. 3,033 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Promethium Advisors held 1,042 shares of Eli Lilly worth $1.21M as of Q3 2026.
Promethium Advisors bought 42 Eli Lilly shares in Q3 2026, an estimated $49.6K.
Eli Lilly made up 0.59% of Promethium Advisors's portfolio in Q3 2026, its #47 holding.
Promethium Advisors first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
3,033 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Promethium Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.